Screening for blood protein conditions using a new test
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial is screening for a condition called monoclonal gammopathy (abnormal proteins in the blood) using a new testing method. It is for people who are already having certain blood tests as part of their medical care or routine checkup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are either a clinical patient (being seen for a health issue) or someone getting a routine physical exam (checkup).
- If you are a clinical patient, you must be at least 18 years old.
- If you are getting a routine physical exam, you must be at least 30 years old.
- You must have already had a blood test for abnormal proteins called SPEP (and if you are a clinical patient, also SIFE and FLC tests).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is screening people over 30 to find a protein in the blood called M protein, which can be a sign of certain blood conditions. If you have it, the study will follow you over time to learn more.
This study is looking for adults at Zhujiang Hospital to test a new, highly sensitive method for detecting a protein called M protein in the blood. It helps doctors understand how common this protein is in different patients.
This study screens adults aged 40 and older for early signs of MGUS (a benign blood condition) and multiple myeloma (a blood cancer). You'll fill out questionnaires about your health to help with early detection.
This study looks at stored blood (serum) samples to see whether a lab test called MALDI-TOF mass spectrometry can help analyze multiple myeloma proteins. If you have multiple myeloma (or are a healthy matched control), your existing lab samples may be used for testing.
This trial screens first-degree relatives of people with multiple myeloma to check for early signs of the disease before symptoms. It may help doctors understand risk in families and find problems sooner if they occur.
This study looks at how your gut bacteria (intestinal flora) and immune system relate to a condition called monoclonal gammopathy, where an abnormal protein is found in the blood. The trial will check samples from your blood, plasma, and stool to understand these connections.
Hear when a new M Protein trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.